Skip to content
Open access

Response to a vaccine-derived poliovirus type 1 event - Sichuan, China, 2024.

Jul 2026 · BMC Infectious Diseases · 0 citations
Medicine

TL;DR

Timely detection and response prevented further spread and development of a circulating VDPV type 1 (cVDPV1) and rapidly raised population immunity in a low-coverage area through a high-quality SIA and interrupted spread of the virus.

Abstract

Background

In September 2024, a 4-month-old infant in Liangshan, Sichuan, China was diagnosed with paralytic poliomyelitis that turned out to have been caused by a vaccine-derived poliovirus type 1 (VDPV1). This was the third VDPV outbreak detected by routine acute flaccid paralysis (AFP) surveillance in Sichuan since 2012. We conducted an epidemiological investigation into the event and implemented response measures to prevent further viral spread.

Methods

The investigation and response were conducted according to World Health Organization (WHO) and China's National Health Commission standard operating procedures. Measures included case and virus verification; search for poliovirus among contacts, healthy children, and in wastewater; active surveillance for AFP cases in health facilities and communities; vaccination coverage assessment; and supplementary immunization activity (SIA) and catch-up vaccination.

Results

The paralyzed infant was determined to be a VDPV1 case by the Sichuan provincial expert group; the VDPV1 had 10-15 nucleotide changes from Sabin strain type 1. No VDPVs were found in close contacts, healthy children, or wastewater; no AFP cases were found in health facilities or communities; no local circulation of the VDPV1 was detected. Following a county-wide SIA with catch-up vaccination, 2-dose, bivalent live attenuated polio vaccine coverage was 95.4% among children four months to four years of age, and full-series polio vaccine coverage was 98.5% in children 5-14 years of age.

Conclusions

The VDPV was an ambiguous VDPV type 1 (aVDPV1). Timely detection and response prevented further spread and development of a circulating VDPV type 1 (cVDPV1). Low vaccination coverage and poor sanitation were contributing factors to the emergence of the aVDPV1. Information technology facilitated the strategy of "Government Locates, Health Vaccinates" that rapidly raised population immunity in a low-coverage area through a high-quality SIA and interrupted spread of the virus. CLINICAL TRIAL NUMBER Not applicable.

Read PDF

Similar papers

Review Open access Aug 2026

Progress toward poliomyelitis eradication — January 2023–December 2024

The resurgence of WPV1 in polio-free regions in Afghanistan and Pakistan and the spread of cVDPVs challenge global polio eradication, highlighting the need for rapid detection, expanded nOPV2 use in areas with prolonged transmission, and sustained partner engagement and strategic resource allocation amid declining glob...

H. Whitmire, M. Z. Wadood, Ina G. Storm et al. · 0 citations
Review Open access Aug 2026

Strategies and lessons learned from a type 1 circulating vaccine-derived poliovirus (cVDPV) outbreak affecting adult population: Madagascar, 2020-2023.

The cVDPV1 outbreak in Madagascar demonstrated the potential for significant adult involvement and high mortality in polio outbreaks, and highlighted the importance of inclusive vaccination strategies and tailored approaches in similar settings.

Kpandja Djawe, Eric Aigbogun, Joseph Souba Zoumanigui et al. · 0 citations
Aug 2026

Immunogenicity of type 2 novel oral poliovirus vaccine administered in outbreak response, Kenya 2023: an observational cohort study.

BACKGROUND In 2023, novel oral polio vaccine type 2 (nOPV2) was used to respond to an outbreak of circulating vaccine-derived poliovirus type 2 (cVDPV2) in Kenya. We assessed the immunogenicity of one and two doses of nOPV2 administered during outbreak response. METHODS An observational cohort study was conducted fro...

A. Anand, Damaris Jepkosgei, C. Mwachari et al. · 0 citations
Open access Jul 2026

Covid-19 Vaccination Uptake Among Remote Communities In Malaysia: A Cross-Sectional Study

The coronavirus disease 2019, or COVID-19, was named the disease by the World Health Organization and poses a significant threat to public health, including Malaysia, and poses a significant threat to public health, including Malaysia.

Maznieda Mahjom, Imanul Hassan Abdul Shukor, M. Arip et al. · 0 citations
Aug 2026

Effectiveness of NmCV-5 vaccine against meningococcal meningitis in an outbreak setting in Niger: results from a case-control study.

BACKGROUND Meningococcal meningitis remains a major public health challenge in Africa's meningitis belt despite the successful elimination of serogroup A epidemics following MenAfriVac introduction. Outbreaks caused by serogroups C, W, and X persist. NmCV-5, a pentavalent conjugate vaccine targeting serogroups A, C, W,...

Laura V Cooper, Médard Djedanem, Assan Abdoul Nasser et al. · 0 citations
Review Open access Jul 2026

Child, Parental, and Household Factors on Inactivated Poliovirus Vaccine Use

Although the immunization program requires OPV vaccine for every infant, outbreaks of polio and Acute Flaccid Paralysis (AFP) still occur frequently, triggering a rapid response of mass immunization. The vaccine of Inactivated Polio Virus (IPV) was added to prevent wild poliovirus which causes paralysis, but its effect...

T. Hardiyanti, Ayun Sriatmi, Martini et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.